Paragon Wealth Strategies’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-22
Closed -$1.09K 95
2022
Q4
$1.09K Hold
22
﹤0.01% 222
2022
Q3
$1K Buy
+22
New +$907 ﹤0.01% 160
2021
Q3
Sell
-22
Closed -$3K 120
2021
Q2
$3K Buy
+22
New +$2.63K ﹤0.01% 254

Other funds holding EXAS

Paragon Wealth Strategies's EXAS Position: Q1 2023 in Review

Paragon Wealth Strategies sold out of Exact Sciences (EXAS) in Q1 2023, closing a stake of 22 shares — an estimated $1.09K sold.

Paragon Wealth Strategies first reported a position in EXAS in Q2 2021 and held it in 3 quarters. The position peaked at $3K in Q2 2021. 584 funds tracked by Wall St. Rank hold EXAS as of Q1 2023.

  • Paragon Wealth Strategies reported no remaining Exact Sciences position as of Q1 2023 after selling out during the quarter.
  • Paragon Wealth Strategies sold 22 Exact Sciences shares in Q1 2023, an estimated $1.09K.
  • Paragon Wealth Strategies first reported a position in Exact Sciences in Q2 2021 and held it in 3 quarters.
  • Paragon Wealth Strategies's Exact Sciences position peaked at $3K in Q2 2021.
  • 584 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2023.

Based on Paragon Wealth Strategies's 13F filing for Q1 2023, filed 26 Apr 2023.